Klickitat Valley Health's fuel cell and microgrid project boosts rural healthcare, enhancing energy resilience and sustainability for social equity.

Scientists are developing ways to detect previously unseen forms of fentanyl as well as other synthetic opioids known as nitazenes.

Three PNNL-supported projects are at the forefront of developing advanced data analytics technologies to enhance the U.S. power grid’s reliability, resilience, and affordability.

A cross-institutional team of scientists developed PeakQC, a new software tool for automated quality control of mass spectrometry data.

Three PNNL technologies have been named 2024 R&D 100 Award winners.

The Grid Storage Launchpad dedication event was attended by leaders in grid and transportation energy storage, battery innovation, and industry stakeholders working to transform America’s energy system.

Ljiljana Paša-Tolić, a PNNL fellow, is the recipient of the 2024 International Mass Spectrometry Foundation’s Jochen Franzen Award. 

Scientists have developed a way to detect tiny amounts of hard-to-detect explosives more than eight feet away.

Erich Hsieh, Deputy Assistant Secretary for OE’s Energy Storage Division, shared insights about the Grid Storage Launchpad and energy storage innovations .

A team of researchers from Pacific Northwest National Laboratory and the Environmental Molecular Sciences Laboratory developed a new and flexible software tool called “Advanced Spectra PCA Toolbox.”

Vigorous exercise burns fat more in males than in females, but the benefits of exercise are broad for both sexes.

Three PNNL-affiliated researchers have been named fellows of the American Association for the Advancement of Science, the world’s largest multidisciplinary scientific society.

PNNL electrical engineer Samrat Acharya led a team that earned the 2024 IEEE Innovative Smart Grid Technologies Conference Best Paper Award.

PNNL scientists have put forth a new approach to protect the electric grid, creating an approach that sorts and prioritizes cyber threats on the fly.

Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes.

PNNL researchers helped identify a fragment from the SARS-CoV-2 virus that spurs severe illness.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

PNNL scientists took thousands of measurements of firefighters in training to learn more about how the body responds to vigorous exercise.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.

Small teams in the Biological Sciences Division at PNNL and at EMSL—the Environmental and Molecular Sciences Laboratory, an Office of Science user facility at PNNL—are pros at preparation.